Clinical trial
A Multicenter Post-Market Study for the Evaluation of the CorPath® GRX technIQ Automated Movements in Percutaneous Coronary Interventions
NCT04883008 is registered in ClinicalTrials.gov with Siemens Healthineers Endovascular Robotics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Post-Market Study for the Evaluation of the CorPath® GRX technIQ Automated Movements in Percutaneous Coronary Interventions
- Lead sponsor
- Siemens Healthineers Endovascular Robotics, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- June 14, 2021
- Completion date
- February 7, 2022
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.